Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug 16:2011:1715.

Fungal toenail infections

Jill Ferrari  1
Affiliations

Fungal toenail infections

Jill Ferrari. BMJ Clin Evid. .

Abstract

Introduction: Fungal infections are reported to cause 23% of foot diseases and 50% of nail conditions in people seen by dermatologists, but are less common in the general population, affecting 3% to 5% of people.

Methods and outcomes: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of oral treatments for fungal toenail infections? What are the effects of topical treatments for fungal toenail infections? We searched: Medline, Embase, The Cochrane Library, and other important databases up to March 2011 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Results: We found 12 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.

Conclusions: In this systematic review we present information relating to the effectiveness and safety of the following interventions: amorolfine, butenafine, ciclopirox, fluconazole, griseofulvin, itraconazole, ketoconazole, mechanical debridement, terbinafine, and tioconazole.

PubMed Disclaimer

References

    1. Hay RJ. The future of onychomycosis therapy may involve a combination of approaches. Br J Dermatol 2001;145(suppl 60):3–8. - PubMed
    1. Williams HC. The epidemiology of onychomycosis in Britain. Br J Dermatol 1993;129:101–109. - PubMed
    1. Evans EGV. The rationale for combination therapy. Br J Dermatol 2001;145(suppl 60):9–13. - PubMed
    1. Zaias N. Onychomycosis. Arch Dermatol 1972;105:263–274. - PubMed
    1. Roseeuw D. Achilles foot screening project: preliminary results of patients screened by dermatologists. J Eur Acad Dermatol Venereol 1999;12(suppl 1):S6–S9. - PubMed

Publication types

LinkOut - more resources